Holding(s) in Company

RNS Number : 1456I
Allergy Therapeutics PLC
13 November 2008
 



For filings with the FSA include the annex

For filings with issuer exclude the annex 


TR-1: Notifications of Major Interests in Shares



1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:


Allergy Therapeutics plc


2. Reason for notification (yes/no)


An acquisition or disposal of voting rights


YES


An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 



An event changing the breakdown of voting rights



Other (please specify):______________



3. Full name of person(s) subject to notification obligation:


Mr C Moreno


4. Full name of shareholder(s) (if different from 3):


N/A


5. Date of transaction (and date on which the threshold is crossed or reached if different):


November 2008


6. Date on which issuer notified:


13 November 2008


7. Threshold(s) that is/are crossed or reached:


4%

8: Notified Details

A: Voting rights attached to shares


Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights


Direct


Indirect


Direct


Indirect


GB00B02LCQ05            Below 3%              Below 3%        3,449,033                  3,449,033     0                      3,449,033     0



B: Financial Instruments


Resulting situation after the triggering transaction


Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights


N/A


N/A


N/A



N/A


N/A


Total (A+B)


Number of voting rights

Percentage of voting rights


3,449,033


4.2%


9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:



Proxy Voting:


10. Name of proxy holder:


N/A

11. Number of voting rights proxy holder will cease to hold:


N/A

12. Date on which proxy holder will cease to hold voting rights:


N/A


13. Additional information:



14 Contact name:


Halifax Share Dealing

15. Contact telephone name:


08457 225525



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUOVNRWORAAAA
UK 100

Latest directors dealings